Cyclosporin a induces renal episodic hypoxia

M Fähling1, S Mathia1,2, J Scheidl3

  • 1Vegetative Physiologie, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Abstract

Insights

Cyclosporin A causes kidney damage by inducing temporary hypoxia. Upregulating hypoxia-inducible factors (Hifs) worsens this renal toxicity, suggesting Hifs are not protective in this context.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Biomedical Imaging

Background:

  • Cyclosporin A (CsA) is known to cause renal toxicity, but the exact mechanisms remain unclear.
  • Renal hypoxia and hypoxia-inducible factors (Hifs) are suspected contributors to CsA-induced kidney damage.

Purpose of the Study:

  • To investigate the presence and role of hypoxia and Hifs in mouse kidneys experiencing CsA-induced toxicity.
  • To analyze the temporal dynamics of hypoxia and Hif activity.
  • To assess the impact of experimentally induced Hif upregulation on CsA nephrotoxicity.

Main Methods:

  • Mice were treated with CsA, with or without a low salt diet, for up to six weeks.
  • Renal function, morphology, and oxygen levels (using blood oxygen level-dependent MRI and pimonidazole adducts) were assessed.
  • Hypoxia-inducible factor alpha (Hif-α) protein levels and target gene expression were analyzed.
  • Stable Hif upregulation was achieved by knocking out the von Hippel-Lindau protein (Vhl).

Main Results:

  • CsA induced transient renal hypoxia and altered vascular reactivity.
  • Combined low salt diet and CsA treatment led to chronic renal failure, tubular damage, and interstitial fibrosis.
  • Affected nephron segments showed accumulation of pimonidazole adducts and Hif-α proteins.
  • Despite Hif-α accumulation, Hif target gene expression was unchanged, but factor-inhibiting Hif (Fih) was upregulated.
  • Interventionally upregulated Hif (via Vhl-KO) worsened the morpho-functional outcomes of chronic CsA toxicity.

Conclusions:

  • Cyclosporin A triggers episodic hypoxia in susceptible nephron segments, contributing to chronic kidney damage.
  • Enhanced factor-inhibiting Hif (Fih) likely limits the cellular response to hypoxia.
  • Sustained upregulation of Hifs through Vhl knockout exacerbates CsA-induced renal toxicity, indicating a detrimental role in this context.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
876
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
564
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.6K
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
1.1K
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.2K
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
1.0K